Mohamed, S.S., Tamer, A.R., Bensaber, S.M., Jaeda, M.I., Ermeli, N.B., Allafi, A.A., Mrema, I.A., Erhuma, M., Hermann, A. and Gbaj, A.M. (2013) Design, Synthesis, Molecular Modeling, and Biological Evaluation of Sulfanilamide-Imines Derivatives as Potential Anticancer Agents. Naunyn-Schmiedeberg’s Archives of Pharmacology, 386, 813-822.
https://doi.org/10.1007/s00210-013-0883-y

has been cited by the following article:

• TITLE: Molecular Modeling and Synthesis of New Heterocyclic Compounds Containing Pyrazole as Anticancer Drugs

  AUTHORS: Fiby N. Takla, Abdelbasset A. Farahat, Magda A.-A. El-Sayed, Magda N. A. Nasr

  KEYWORDS: Tubulin, CA-4, Anticancer, Pyrazole, Molecular Modeling

  JOURNAL NAME: International Journal of Organic Chemistry, Vol.7 No.4, December 15, 2017

  ABSTRACT: Several modifications in CA-4 were reported in literature for the development of various tubulin inhibitors. In our study, twenty-two newly synthesized heterocyclic derivatives of Combretastatin A-4 (CA-4) have been tested for their cytotoxic effect on four different types of cells with malignant behavior using CA-4 as a positive control. Compounds 5b, 15 and 16 showed the foremost potent antiproliferative activities as compared to CA-4 with IC50 starting from 6.9 to 13.7 μM. Molecular docking was performed with the crystal structure of tubulin employing a potent tubulin inhibitor CA-4 as a parent molecule. Molecular study advised that 5b, 15, 16 and 17 are promising tubulin inhibitors.